Komori
Terumo (4543) · PolicyAdvanced

Growth investment exceeding the cost of capital and capital management focused on asset efficiency and financial soundness

First written in FY2019. 2 of 8 entries say "Advanced", first in FY2025. Latest entry: FY2026.

8entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2019 – FY2024AdvancedFY2025 – FY20262019: 120192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Balancing Growth Investment with Strengthening the Financial BaseA theme 69 companies write about · 0 as a headwind · 69 as a tailwind

13 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 69 companies compared. The sentences above are computed from all 69.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「ROIC 7.5 7.5 ROE 8.7 9.2」

    The policy focused on growth investment exceeding the cost of capital, asset efficiency and financial soundness continued. ROIC was flat at 7.5%, while ROE improved from 8.7% to 9.2%, but the GS26 targets of at least 10% for ROIC and at least 10% for ROE were not met.
  2. FY2025AdvancedAnnual report

    「ROIC 7.1 7.5 ROE 8.7 8.7」

    The capital management policy focused on growth investment exceeding the cost of capital, asset efficiency and financial soundness continued, and ROIC improved from 7.1% to 7.5%. ROE was 8.7%, below the GS26 target of at least 10%.
  3. FY2024ROIC and ROE Improved but Targets Were Not MetAnnual report

    「ROIC was 7.1%, compared with 6.8%, and ROE was 8.7%, compared with 8.4%.」

    The capital management policy focused on growth investment exceeding the cost of capital, asset efficiency and financial soundness continued, and both ROIC and ROE improved from the previous fiscal year. However, the GS26 targets of at least 10% for ROIC and at least 10% for ROE have not been met.
  4. FY2023ROIC and ROE DeclinedAnnual report

    「ROIC was 6.8%, compared with 7.4%, and ROE was 8.4%, compared with 9.5%.」

    The capital management policy focused on growth investment exceeding the cost of capital, asset efficiency and financial soundness continued, while both ROIC and ROE declined from the previous fiscal year and fell below the GS26 targets of at least 10% for ROIC and at least 10% for ROE.
  5. FY2022ROE Target Remains UnmetAnnual report

    「ROIC was 7.2%, compared with 7.4%, and ROE was 9.6%, compared with 9.5%.」

    The capital management policy focused on growth investment exceeding the cost of capital, asset efficiency and financial soundness continued, while ROE declined from 9.6% in the previous fiscal year to 9.5%, below the GS26 target of at least 10%.
  6. FY2021Decline in ROEAnnual report

    「Profit attributable to owners of the parent as a percentage of equity 11.7 % 9.6 %」

    The capital management policy focused on growth investment exceeding the cost of capital, asset efficiency and financial soundness continued, but ROE declined from 11.7% in the previous fiscal year to 9.6%.
  7. FY2020RestatedAnnual report

    「To enhance corporate value, the Group pursues growth investment opportunities that exceed the cost of capital and has adopted as its basic capital management policy the improvement of asset efficiency through business operation improvements and the establishment of an appropriate capital structure that also takes financial soundness into account.」

    The capital management policy focused on growth investment exceeding the cost of capital, asset efficiency, financial soundness, ROE and EPS continued. ROE was 11.7% in FY2020.
  8. FY2019First statedAnnual report

    「As its basic capital policy, the Group states that it aims to improve return on equity (ROE) and grow earnings per share (EPS) by improving asset efficiency through measures such as business operation improvements and establishing an appropriate capital structure that also takes financial soundness into account.」

    The Group newly set out a basic capital policy that considers growth investment opportunities, asset efficiency, financial soundness, and improvements in ROE and EPS in an integrated manner.
Moved together

"Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets" moved the same way as this thread, in the same document, in 2 of its 8 moves.

222222★123456
  1. ★This thread
  2. 1Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets2×
  3. 2Expanding market share in global markets and enhancing brand value2×
  4. 3Global sales expansion of cardiovascular products such as Ultimaster2×
  5. 4Managing Business Performance Using Adjusted Operating Profit2×
  6. 5Changes in Debt Composition Due to Bond Issuance and Repayment of Long-Term Borrowings2×
  7. 6High-value-added products and services that contribute to reducing patients’ financial burden, improving medical safety, and enhancing operational efficiency2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.